Rectointercostal Plane Block (RICPB) for Laparoscopic Cholecystectomy

Sponsor
Koç University
Study ID
NCT07676552
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Cholelithiasis
  • Postoperative Pain

Eligibility Criteria

Sex
ALL
Age
18 Years - 65 Years
Healthy Volunteers
Not accepted

Interventions

  • Rectointercostal Plane Block — PROCEDURE
    Ultrasound-guided unilateral right-sided rectointercostal plane block (RICPB) will be performed at the end of surgery before emergence from anesthesia. A total of 30 mL of 0.25% bupivacaine will be injected into the rectointercostal plane under ultrasound guidance.
  • Port-Site Local Anesthetic Infiltration — PROCEDURE
    Conventional port-site local anesthetic infiltration will be performed at the end of surgery according to the study protocol to provide postoperative analgesia.

Study Details

This prospective randomized controlled trial is designed to evaluate the analgesic efficacy of ultrasound-guided rectointercostal plane block (RICPB) in patients undergoing elective laparoscopic cholecystectomy. Patients will be randomized to receive unilateral right-sided RICPB at the end of surgery. Postoperative opioid consumption, Numeric Rating Scale (NRS) pain scores, and postoperative complications will be assessed to determine the effectiveness of RICPB in postoperative pain management.

Key Dates

First listed
Jun 30, 2026
Start date
Jul 1, 2026
Status verified
Jun 2026
Primary completion
Jan 31, 2027
Completion
Feb 1, 2027

Study Design

Enrollment
60 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: RICPB Group
    Participants will receive an ultrasound-guided unilateral right-sided rectointercostal plane block (RICPB) with 30 mL of 0.25% bupivacaine at the end of surgery before emergence from anesthesia.
  • Active Comparator: Port-Site Infiltration Group
    Participants will receive conventional port-site local anesthetic infiltration at the end of surgery according to the study protocol.

Primary Outcome Measure

Cumulative Postoperative Morphine Consumption [ Time Frame: Postoperative 24 hours ]

Central Contacts

Related Studies